Definition of hidden drug cardiotoxicity: paradigm change in cardiac safety testing and its clinical implications-Reference-Cited by-同舟云学术

Definition of hidden drug cardiotoxicity: paradigm change in cardiac safety testing and its clinical implications

Published:2018-07-02 Issue:22 Volume:40 Page:1771-1777
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Ferdinandy Péter¹²,Baczkó István³,Bencsik Péter²,Giricz Zoltán¹²,Görbe Anikó¹²,Pacher Pál⁴,Varga Zoltán V¹⁴,Varró András³,Schulz Rainer⁵

Affiliation:

1. Department of Pharmacology and Pharmacotherapy, Semmelweis University, Nagyvárad tér 4, Budapest, Hungary

2. Pharmahungary Group, Hajnoczy u. 6, Szeged, Hungary

3. Department of Pharmacology and Pharmacotherapy, University of Szeged, Dóm tér 12, Szeged, Hungary

4. Laboratory of Cardiovascular Physiology and Tissue Injury, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Fishers Lane, Bethesda, MD, USA

5. Institute of Physiology, Justus-Liebig University of Giessen, Aulweg 129, Giessen, Germany

Funder

European Co-operation in Science and Technology

Hungarian National Research, Development, and Innovation Office

German Research Foundation

Higher Education Institutional Excellence Programme of the Ministry of Human Capacities in Hungary

Therapeutic Development

Semmelweis University

Premium Postdoctoral Fellowship Program of the Hungarian Academy of Sciences

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/40/22/1771/28772176/ehy365.pdf

Reference136 articles.

1. Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature;Onakpoya;BMC Med,2016

2. Worldwide withdrawal of medicinal products because of adverse drug reactions: a systematic review and analysis;Onakpoya;Crit Rev Toxicol,2016

3. Post-marketing withdrawal of analgesic medications because of adverse drug reactions: a systematic review;Onakpoya;Expert Opin Drug Saf,2018

4. Effective analgesic doses of tramadol or tapentadol induce brain, lung and heart toxicity in Wistar rats;Faria;Toxicology,2017

5. . Drug-induced torsades de pointes and implications for drug development;Fenichel;J Cardiovasc Electrophysiol,2004

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Current State of Realistic Heart Models for Disease Modelling and Cardiotoxicity;International Journal of Molecular Sciences;2024-08-24

2. Empagliflozin prevents heart failure through inhibition of the NHE1-NO pathway, independent of SGLT2;Basic Research in Cardiology;2024-07-24

3. Preclinical models of cardiotoxicity from immune checkpoint inhibitor therapy;Basic Research in Cardiology;2024-07-22

4. Anthracyclines, Diastolic Dysfunction and the road to Heart Failure in Cancer survivors: An untold story;Progress in Cardiovascular Diseases;2024-07

5. In vitro to in vivo extrapolation from 3D hiPSC-derived cardiac microtissues and physiologically based pharmacokinetic modeling to inform next-generation arrhythmia risk assessment;Toxicological Sciences;2024-06-19